The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 06, 2024

Filed:

Sep. 08, 2022
Applicants:

Bayer Aktiengesellschaft, Leverkusen, DE;

Bayer Pharma Aktiengesellschaft, Berlin, DE;

The Broad Institute, Inc., Cambridge, MA (US);

Inventors:

Kai Thede, Leverkusen, DE;

Anne Mengel, Leverkusen, DE;

Clara Christ, Leverkusen, DE;

Joachim Kuhnke, Leverkusen, DE;

Sarah Anna Liesa Johannes, Leverkusen, DE;

Philipp Buchgraber, Leverkusen, DE;

Ulrich Klar, Leverkusen, DE;

Ulrike Rauh, Leverkusen, DE;

Stefan Kaulfuss, Leverkusen, DE;

Amaury Ernesto Fernandez-Montalvan, Leverkusen, DE;

Nicolas Werbeck, Leverkusen, DE;

Ursula Moenning, Leverkusen, DE;

Katrin Nowak-Reppel, Leverkusen, DE;

Sven Wittrock, Leverkusen, DE;

David McKinney, Cambridge, MA (US);

Michael H. Serrano-Wu, Cambridge, MA (US);

Chris Lemke, Cambridge, MA (US);

Mark Fitzgerald, Cambridge, MA (US);

Christopher Nasveschuk, Cambridge, MA (US);

Kiel Lazarski, Cambridge, MA (US);

Steven James Ferrara, Cambridge, MA (US);

Laura Furst, Cambridge, MA (US);

Guo Wei, Cambridge, MA (US);

Patrick Ryan McCarren, Cambridge, MA (US);

Rebecca Ann Harvey, Lancashire, GB;

Assignees:

Bayer Aktiengesellschaft, Leverkusen, DE;

Bayer Pharma Aktiengesellschaft, Berlin, DE;

The Broad Institute, Inc., Cambridge, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 498/14 (2006.01); A61P 35/02 (2006.01); A61P 35/00 (2006.01); A61K 31/4162 (2006.01); A61K 31/437 (2006.01); A61K 31/496 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01); C07D 471/22 (2006.01); C07D 487/14 (2006.01); C07D 487/22 (2006.01); C07D 498/22 (2006.01);
U.S. Cl.
CPC ...
C07D 498/14 (2013.01); A61K 31/4162 (2013.01); A61K 31/437 (2013.01); A61K 31/496 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); C07D 471/22 (2013.01); C07D 487/14 (2013.01); C07D 487/22 (2013.01); C07D 498/22 (2013.01);
Abstract

The present invention relates to substituted macrocyclic indole derivatives of general formula (I): in which R, R, R, R, R, R, A and L are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients.


Find Patent Forward Citations

Loading…